Intralesional treatment of stage III metastatic melanoma patients with L19-IL2: Clinical and systemic immunological responses

Authors :: Ralf Gutzmer
Claus Garbe
Giuliano Elia
Leonardo Giovannoni
Benjamin Weide
Annette Pflugfelder
Thomas Eigentler
Juergen C. Becker
Pier Adelchi Ruffini
Graham Pawelec
Henning Zelba
Dario Neri
Source :: ResearcherID
Publication Year :: 2014
Publisher :: American Society of Clinical Oncology (ASCO), 2014.
Abstract: 9041^ Background: In previous studies, intralesional injection with interleukin-2 (IL2) showed efficacy for the intratumoral treatment of cutaneous/subcutaneous metastases in advanced melanoma pati...

Subjects :: Cancer Research
Pathology
medicine.medical_specialty
Oncology
Metastatic melanoma
business.industry
Medicine
Stage (cooking)
business
Advanced melanoma

Full Text Access

Tools